The use of transgenic and mutant mice to study oxygen free radical metabolism

Annals of the New York Academy of Sciences

Volumn 893, Issue , 1999, Pages 95-112

  Huang, Ting Ting ^a   Carlson, Elaine J ^a   Raineri, Ines ^a   Gillespie, Anne Marie ^a   Kozy, Heather ^a   Epstein, Charles J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACONITATE HYDRATASE; CD1 ANTIGEN; COPPER ZINC SUPEROXIDE DISMUTASE; LIPID; MANGANESE SUPEROXIDE DISMUTASE; MITOCHONDRIAL ENZYME; OXYGEN RADICAL; SUCCINATE DEHYDROGENASE;

ANIMAL EXPERIMENT; ATAXIA; CAUSE OF DEATH; CONFERENCE PAPER; CONGENITAL HEART MALFORMATION; CONTROLLED STUDY; GENETICS; HEART DILATATION; KETOACIDOSIS; LIFESPAN; LIPID LIVER LEVEL; LIPID STORAGE; MEDICAL RESEARCH; METABOLIC ACIDOSIS; METABOLISM; MOUSE; MOUSE MUTANT; NERVE DEGENERATION; NONHUMAN; PHENOTYPE; SEIZURE; SKELETAL MUSCLE; TRANSGENIC MOUSE;

ANIMALIA; ATAXIA; MUS MUSCULUS;

EID: 0033372631     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb07820.x     Document Type: Conference Paper

References (57)

1. 1. Epstein, C.J., K.B. Avraham, M. Lovett, S. Smith, O. Elroy-Stein, G. Rotman, C. Bry & Y. Groner. 1987. Transgenic mice with increased CuZn-superoxide dismutase activity: an animal model of dosage effects in Down syndrome. Proc. Natl. Acad. Sci. USA 84: 8044-8048.
2. 2. Li, Y., T.-T. Huang, E.J. Carlson, S. Melov, P.C. Ursell, J.L. Olson, L.J. Noble, M.P. Yoshimura, C. Berger, P.H. Chan, D.C. Wallace & C.J. Epstein. 1995. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nature Genet. 11: 376-381.
3. 3. Huang, T.-T., M. Yasunami, E.J. Carlson, A.M. Gillespie, A.G. Reaume, E.K. Hoffman, P.H. Chan, R.W. Scott & C.J. Epstein. 1997. Superoxide-mediated cytotoxicity in superoxide dismutase - deficient fetal fibroblasts. Arch. Biochem. Biophys. 344: 424-432.
4. 4. Huang, T.-T., E.J. Carlson, A.M. Gillespie, Y. Shi & C.J. Epstein. 1999. Ubiquitous overexpression of CuZn superoxide dismutase does not extend life span in mice. J. Gerontol. Biol. Sci. In press.
5. 5. Sun, J. & J. Tower. 1999. FLP recombinase-mediated induction of Cu/Zn-superoxide dismutase transgene expression can extend the life span of adult Drosophila melanogaster flies. Mol. Cell Biol. 9: 216-228.
6. 6. Chan, P.H., G.Y. Yang, S.F. Chen, E. Carlson & C.J. Epstein. 1991. Cold-induced brain edema and infarction are reduced in transgenic mice overexpressing CuZn-superoxide dismutase. Ann. Neurol. 29: 482-486.
7. 7. Mikawa, S., H. Kinouchi, H. Kamii, G.T. Gobbel, S.F. Chen, E. Carlson, C.J. Epstein & P.H. Chan. 1996. Attenuation of acute and chronic damage following traumatic brain injury in CuZn-superoxide dismutase transgenic mice. J. Neurosurg. 85: 885-891.
8. 8. Kinouchi, H., C.J. Epstein, T. Mizui, E. Carlson, S. Chen & P.H. Chan. 1991. Attenuation of focal cerebral ischemia in transgenic mice overexpressing CuZn-superoxide dismutase. Proc. Natl. Acad. Sci. USA 88: 11158-11162.
9. 9. Yang, G., P.H. Chan, J. Chen, E. Carlson, S.F. Chen, P. Weinstein, C.J. Epstein & H. Kamii. 1994. Human copper-zinc superoxide dismutase transgenic mice are highly resistant to reperfusion injury after focal cerebral ischemia. Stroke 25: 165-170.
10. 10. Murakami, K., T. Kondo, C.J. Epstein & P.H. Chan. 1997. Overexpression of CuZn-superoxide dismutase reduces hippocampal injury following ischemia in transgenic mice. Stroke 28: 1797-1804.
11. 11. Kamii, H., H. Kinouchi, F.R. Sharp, J. Koistinaho, C.J. Epstein & P.H. Chan. 1994. Prolonged expression of hsp70 mRNA following transient focal cerebral ischemia in transgenic mice overexpressing CuZn-superoxide dismutase. J. Cereb. Blood Flow Metab. 14: 478-486.
12. 12. Kamii, H., H. Kinouchi, F.R. Sharp, C.J. Epstein, S.M. Sagar & P.H. Chan. 1994. C-fos mRNA expression after a mild focal brain ischemia in SOD-1 transgenic mice. Brain Res. 662: 240-244.
13. 13. Mikawa, S., F.R. Sharp, H. Kamii, H. Kinouchi, C.J. Epstein & P.H. Chan. 1995. Expression of hsp70 and c-fos mRNA after traumatic brain injury in transgenic mice overexpressing CuZn-superoxide dismutase. Mol. Brain Res. 33: 288-294.
14. 14. Kondo, T., K. Murakami, J. Honkaniemi, F.R. Sharp, C.J. Epstein & P.H. Chan. 1996. Expression of hsp70 mRNA is induced in the brain of transgenic mice overexpressing human CuZn-superoxide dismutase following transient global cerebral ischemia. Brain Res. 737: 321-326.
15. 15. Chan, P.H., H. Kamii, G. Yang, J. Gafni, C.J. Epstein, E. Carlson & L. Reola. 1993. Brain infarction is not reduced in SOD-1 transgenic mice after a permanent focal cerebral ischemia. NeuroReport 5: 293-296.
16. 16. Ditelberg, J.S., R.A. Sheldon, C.J. Epstein & D.M. Ferriero. 1996. Brain injury after perinatal hypoxia-ischemia is exacerbated in copper/zinc superoxide dismutase transgenic mice. Ped. Res. 39: 204-208.
17. 17. Przedborski, S., V. Kostic, V. Jackson-Lewis, A.B. Naini, S. Fahn, E. Carlson, C.J. Epstein & J.L. Cadet. 1992. Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity. J. Neurosci. 12: 1658-1667.
18. 2-MPTP on serotonergic and noradrenergic nerve terminals. Mol. Pharmacol. 50: 1511-1519.
19. 19. Cadet, J.L., P. Sheng, S. Ali, R. Rothman, E. Carlson & C.J. Epstein. 1994. Attenuation of methamphetamine-induced neurotoxicity in copper/zinc superoxide dismutase transgenic mice. J. Neurochem. 62: 380-383.
20. 20. Cadet, J.L., B. Ladenheim, I. Baum, E. Carlson & C.J. Epstein. 1994. CuZn-superoxide dismutase (CuZn SOD) transgenic mice show resistance of the lethal effects of methylenedioxyamphetamine (MDA) and of methylenedioxymethamphetamine (MDMA). Brain Res. 655: 259-262.
21. 21. Cadet, J.L., B. Ladenheim, R.B. Rothman, E. Carlson, C.J. Epstein & T.H. Moran. 1995. Superoxide radicals mediate the neurotoxicity of methylenedioxymethamphetamine (MDMA): evidence from using CuZn-superoxide dismutase transgenic mice. Synapse 21: 169-176.
22. 22. Hirata, H., B. Ladenheim, R. B. Rothman, C.J. Epstein & J.L. Cadet. 1995. Methamphetamine-induced serotonin neurotoxicity is mediated by superoxide radicals. Brain Res. 677: 345-347.
23. 23. Hirata, H., B. Ladenheim, E. Carlson, C. Epstein & J.L. Cadet. 1996. Autoradiographic evidence for methamphetamine-induced striatal dopaminergic loss in mouse brain - attenuation in CuZn-superoxide dismutase transgenic mice. Brain Res. 714: 95-103.
24. 24. Beal, M.F., R.J. Ferrante, R. Henshaw, R.T. Matthews, P.H. Chan, N.W. Korvall, C.J. Epstein & J.B. Schulz. 1995. 3-Nitropropionic acid neurotoxicity is attenuated in copper/zinc superoxide dismutase transgenic mice. J. Neurochem. 65: 919-922.
25. 25. Kondo, T., F.R. Sharp, J. Honkaniemi, S. Mikawa, C.J. Epstein & P.H. Chan. 1997. DNA fragmentation and prolonged expression of c-fos, c-jun and hsp70 in kainic acid - induced neuronal cell death in transgenic mice overexpressing human CuZn-superoxide dismutase. J. Cereb. Blood Flow Metab. 17: 241-256.
26. 26. Friedlich, A.L., T.W. Farris, E. Carlson, C.J. Epstein & L.L. Butcher. 1993. β-amyloid protein-induced neurotoxicity in wild type mice and in transgenic mice with elevated CuZn superoxide dismutase activity. Soc. Neurosci. Abstr. 19: 1036.
27. 27. Raber, J., S.M. Toggas, S. Lee, F.E. Bloom, C. Epstein & L. Mucke. 1996. Central nervous system expression of HIV-1 Gp120 activates the hypothalamic-pituitary-adrenal axis: evidence for involvement of NMDA receptors and nitric oxide synthase. Virology 226: 362-373.
28. 28. Nakao, N., E.M. Frodl, H. Widner, E. Carlson, S.K. Cho, C.J. Epstein & P. Brundin. 1995. Overexpressing Cu/Zn superoxide dismutase enhances survival of transplanted neurons in a rat model of Parkinson's disease. Nature Med. 1: 226-231.
29. 29. Przedborski, S., U. Khan, V. Kostic, E. Carlson, C. Epstein & D. Sulzer. 1996. Increased superoxide dismutase activity improves survival of cultured postnatal midbrain neurons. J. Neurochem. 67: 1383-1392.
30. 30. Sanchez-Ramos, J.R., S. Song, A. Facca, A. Basit & C.J. Epstein. 1997. Transgenic murine dopaminergic neurons expressing human Cu/Zn superoxide dismutase exhibit increased density in culture, but no resistance to methylphenylpyridium-induced degeneration. J. Neurochem. 68: 58-67.
31. 31. Mena, M.A., U. Khan, D.M. Togasaki, D. Sulzer, C.J. Epstein & S. Przedborski. 1997. Effects of wild-type and mutated copper/zinc superoxide dismutase on neuronal survival and L-DOPA - induced toxicity in postnatal midbrain culture. J. Neurochem. 69: 21-33.
32. 32. Fullerton, H.J., J.S. Ditelberg, S.F. Chen, D.P. Sarco, P.H. Chan, C.J. Epstein & D.M. Ferriero. 1998. Copper/zinc superoxide dismutase transgenic brain accumulates hydrogen peroxide after perinatal hypoxia ischemia. Ann. Neurol. 44: 357-364.
33. 33. Chan, P.H., M. Kawase, K. Murakami, S.F. Chen, Y. Li, B. Calagui, L. Reola, E. Carlson & C.J. Epstein. 1998. Overexpression of SOD1 in rats protects vulnerable neurons against ischemic damage after global cerebral ischemia and reperfusion. J. Neurosci. 18: 8292-8299.
34. 34. Kujirai, K., V. Jackson-Lewis, E. Carlson, C.J. Epstein & J.L. Cadet. 1994. Autoradiographic distribution of μ opioid receptors in the brains of Cu/Zn-superoxide dismutase mice. Synapse 17: 76-83.
35. 35. Elmer, G.I., J.L. Evans, B. Ladenheim, C.J. Epstein & J.L. Cadet. 1995. Transgenic superoxide dismutase mice differ in opioid-induced analgesia. Eur. J. Pharmacol. 283: 227-232.
36. 36. Elmer, G.I., J.L. Evans, S.R. Goldberg, C.J. Epstein, C.J. & J.L. Cadet. 1996. Transgenic superoxide dismutase mice: increased mesolimbic μ-opioid receptors result in greater opioid-induced stimulation and opioid-reinforced behavior. Behav. Pharmacol. 7: 628-638.
37. 37. Avraham, K.B., M. Schickler, D. Sapoznikov, R. Yarom & Y. Groner. 1988. Down's syndrome: abnormal neuromuscular junction in tongue of transgenic mice with elevated levels of human Cu/Zn-superoxide dismutase. Cell 54: 823-829.
38. 38. Avraham, K.B., H. Sugarman, S. Rotshenker & Y. Groner. 1991. Down's syndrome: morphological remodelling and increased complexity in the neuromuscular junction of transgenic CuZn-superoxide dismutase mice. J. Neurocytol. 20: 208-215.
39. 39. Reaume, A.G., J.L. Elliott, E.K. Hoffman, N.W. Kowall, R.J. Ferrante, D.F. Siwek, I.M. Wilcox, D.G. Flood, M.F. Beal, R.H.J. Brown, R.W. Scott & W.D. Snider. 1996. Motor neurons in Cu/Zn superoxide-dismutase - deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nature Genet. 13: 43-47.
40. 40. Kondo, T., A.G. Reaume, T.-T. Huang, E. Carlson, K. Murakami, S.F. Chen, E.K. Hoffman, R.W. Scott, C.J. Epstein & P.H. Chan. 1997. Reduction of CuZn-superoxide dismutase activity exacerbates neuronal cell injury and edema formation following transient focal cerebral ischemia. J. Neurosci. 17: 4180-4189.
41. 41. Ho, Y.S., R. Vincent, M.S. Dey, J.W. Slot & J.D. Crapo. 1998. Transgenic models for the study of lung antioxidant defense: enhanced manganese-containing superoxide dismutase activity gives partial protection to B6C3 hybrid mice exposed to hyperoxia. Am. J. Respir. Cell Mol. Biol. 18: 538-547.
42. 42. Chen, Z., B. Siu, Y.S. Ho, R. Vincent, C.C. Chua, R.C. Hamdy & B.H. Chua. 1998. Overexpression of MnSOD protects against myocardial ischemia/reperfusion injury in transgenic mice. J. Mol. Cell. Cardiol. 30: 2281-2289.
43. 43. Yen, H.C., T.D. Oberley, C.G. Gairola, L.I. Szweda & D.K. St. Clair. 1999. Manganese superoxide dismutase protects mitochondrial complex I against adriamycin-induced cardiomyopathy in transgenic mice. Arch. Biochem. Biophys. 362: 59-66.
44. 44. Klivenyi, P., D. St. Clair, M. Wermer, H.C. Yen, T. Oberley, L. Yang & M.F. Beal. 1998. Manganese superoxide dismutase overexpression attenuates MPTP toxicity. Neurobiol. Dis . 5: 253-258.
45. 45. Melov, S., P. Coskun, M. Patel, R. Tuinstra, B. Cottrell, A.S. Jun, T.H. Zastawny, M. Dizdaroglu, S.I. Goodman, T.-T. Huang, H. Miziorko, C.J. Epstein & D.C. Wallace. 1999. Mitochondrial disease in superoxide dismutase 2 mutant mice. Proc. Natl. Acad. Sci. USA 96: 846-851.
46. 46. Zhang, Y., O. Marcillat, C. Giulivi, L. Ernster & K.J. Davies. 1990. The oxidative inactivation of mitochondrial electron transport chain components and ATPase. J. Biol. Chem. 265: 16330-16336.
47. 47. Gardner, P.R., D.D. Nguyen & C.W. White. 1994. Aconitase is a sensitive and critical target of oxygen poisoning in cultured mammalian cells and in rat lungs. Proc. Natl. Acad. Sci. USA 91: 12248-12252.
48. 48. Roberts J.R., C. Narasinham, P.W. Hruz, G.A. Mitchell & H.M. Miziorko. 1994. Evaluation of cysteine 266 of human 3-hydroxy-3-methylglutaryl-CoA lyase as a catalytic residue. J. Biol. Chem. 269: 17841-17846.
49. 49. Roberts J.R., G.A. Mitchell & H.M. Miziorko. 1994. Modeling of a mutation responsible for human 3-hydroxy-3-methylglutaryl-CoA lyase deficiency implicates histidine 233 as an active site residue. J. Biol. Chem. 271: 24604-24609.
50. 50. Williams, M.D., H. Van Remmen, C.C. Conrad, T.T. Huang, C.J. Epstein & A. Richardson. 1998. Reduced Mn-superoxide dismutase activity in heterozygous manganese superoxide dismutase mice is correlated to altered mitochondrial function and increased oxidative damage. J. Biol. Chem. 273: 28510-28515.
51. 51. Van Remmen, H., C. Salvador, H. Yang, T.T. Huang, C.J. Epstein & A. Richardson. 1999. Characterization of the antioxidant status of the heterozygous manganese superoxide dismutase mouse. Arch. Biochem. Biophys. 363: 91-97.
52. 52. Murakami, K., T. Kondo, M. Kawase, Y. Li, S. Sato, S.F. Chen & P.H. Chan. 1998. Mitochondrial susceptibility to oxidative stress exacerbates cerebral infarction that follows permanent focal cerebral ischemia in mutant mice with manganese superoxide dismutase deficiency. J. Neurosci. 18: 205-213.
53. 53. Li, Y., J.-C. Copin, L.F. Reola, B. Calagui, G.T. Gobbel, S.F. Chen, S. Sato, C.J. Epstein & P.H. Chan. 1998. Reduced mitochondrial manganese-superoxide dismutase activity exacerbates glutamate toxicity in cultured mouse cortical neurons. Brain Res. 814: 164-170.
54. 54. Lebovitz, R.M., H. Zhang, H. Vogel, J. Cartwright, Jr., L. Dionne, N. Lu, S. Huang & M.M. Maztuk. 1996. Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase - deficient mice. Proc. Natl. Acad. Sci. USA 93: 9782-9787.
55. 55. Threadgill, D.W. et al. 1995. Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science 269: 230-234.
56. 56. Rozmahel, R., M. Wilschanski, A. Matin, S. Plyte, M. Oliver, W. Auerbach, A. Moore, J. Fostner, P. Durie, J. Nadeau, C. Bear & L.C. Tsui. 1996. Modulation of disease severity in cystic fibrosis transmembrane conductance regulator - deficient mice by a secondary genetic factor. Nature Genet. 12: 280-287.
57. 57. Huang, T.-T., E.J. Carlson, A.M. Gillespie & C.J. Epstein. 1998. Genetic modification of the dilated cardiomyopathy and neonatal lethality phenotype of mice lacking manganese superoxide dismutase. Age 21: 39-40.